Please assess the completion status of the following clinical trial:

Trial Title: A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Must have a diagnosis of acute bacterial conjunctivitis and exhibit purulent conjunctival discharge and redness in at least one eye.~* Females of childbearing potential must utilized reliable contraceptive methods and have a negative pregnancy test.~Exclusion Criteria:~* Pregnant or nursing females.~* Known hypersensitivity to fluoroquinolones or to any of the study ingredients.~* Use of any antibiotic within 72 hours of treatment.~* Any disease or condition that could interfere with the safety and efficacy evaluations of the study medications.~* Participation in an ophthalmic drug or device research study within 30 days prior to entry into the study.

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ISV-403 (Type: EXPERIMENTAL): 0.6% ISV-403 ophthalmic suspension
- Vehicle (Type: PLACEBO_COMPARATOR): Vehicle of ISV-403 ophthalmic suspension

Based on this trial design, predict the completion outcome and termination type (if applicable).